Opinion

Video

How Does GvHD Typically Present?

Author(s):

Hana Safah, MD,Corey S. Cutler, MD, MPH, FRCPC

Hematologist-oncologists Corey Cutler, MD, MPH, and Hana Safah, MD, discuss how graft-vs-host disease presents and the importance of early intervention.

Related Videos
1 expert in this video
1 expert in this video
Minoo Battiwalla, MD, MS
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.
Nancy U. Lin, MD, discusses the safety data from DESTINY-Breast12 with T-DXd for HER2+ advanced/metastatic breast cancer with or without brain metastases.
Daniel DeAngelo, MD, PhD, discusses how the shift away from chemotherapy has affected the management of chronic lymphocytic leukemia.
2 KOLs are featured in this series.
Related Content
Dana-Farber Cancer Institute Faculty Among Highly Cited Researchers | Image Credit: © Cornflakesei - stock.adobe.com
November 21st 2024

Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers for 2024

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Natural Killer Cells in Ovarian Cancer | Image Credit: © Dr_Microbe - stock.adobe.com
November 18th 2024

First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-Farber

Narjust Florez, MD
September 5th 2024

Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions

Acute Myeloid Leukemia
November 15th 2024

Venetoclax Plus 10-Day Decitabine Produces Responses in High-Risk MDS, AML

FDA
November 14th 2024

FDA Approves Nilotinib Tablets Without Mealtime Restrictions for CML